Research programme: radiation injury therapeutics - iNtRON Biotehnology/Korea Institute of Civil Engineering and Building Technology
Latest Information Update: 09 Oct 2014
At a glance
- Originator iNtRON Biotechnology
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Radiation injuries
Most Recent Events
- 11 Aug 2014 Early research in Radiation injuries in South Korea (unspecified route)